Used as a chiral reducing agent in asymmetric synthesis, particularly in the pharmaceutical industry for the production of enantiomerically pure compounds. It facilitates the selective reduction of prochiral ketones and imines, enabling efficient synthesis of active pharmaceutical ingredients (APIs) with high optical purity. Its stability and selectivity make it suitable for use in late-stage transformations where functional group tolerance is critical. Also employed in research settings for developing new synthetic routes in medicinal chemistry and fine chemical manufacturing.